Eam Investors, LLC Enanta Pharmaceuticals Inc Transaction History

Eam Investors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$56.06 - $74.11 $1.73 Million - $2.29 Million	-30,839 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$60.19 - $97.37 $1.86 Million - $3 Million	30,839 New	30,839 $2.31 Million
Q3 2018 Nov 08, 2018	SELL	$85.46 - $126.37 $536,261 - $792,971	-6,275 Closed	0 $0
Q2 2018 Aug 03, 2018	SELL	$81.85 - $120.51 $316,186 - $465,530	-3,863 Reduced 38.1%	6,275 $727,000
Q1 2018 May 14, 2018	BUY	$57.91 - $92.15 $587,091 - $934,216	10,138 New	10,138 $820,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $178M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Eam Investors, LLC, based on Form 13F filings with the SEC.

Stay updated on Eam Investors, LLC with notifications on news.